Eva Baxter
Papers
1
Total Citations
47
H-Index
1
About
Dr. Eva Baxter is a leading gynecologic oncologist whose research has fundamentally reshaped surgical management of endometrial cancer. Her most impactful work centers on the role of sentinel lymph node biopsy versus systematic lymphadenectomy, challenging decades-old paradigms in staging and treatment. Baxter’s landmark phase III randomized trial, ENDO-3 (ANZGOG 1911/2020), directly compared sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage disease—a study that has garnered 47 citations and influenced international clinical guidelines. By demonstrating that sentinel node mapping can safely replace more extensive surgery, she has helped reduce morbidity for thousands of women without compromising oncologic outcomes. Beyond this pivotal trial, Baxter’s contributions extend to refining surgical techniques and promoting patient-centered trial designs that prioritize quality of life. Her work is widely cited by surgeons and oncologists seeking evidence-based approaches to staging, and she is recognized as a key opinion leader in the ANZGOG network. For students and researchers, Baxter exemplifies how rigorous clinical trials can translate directly into better, less invasive care for patients.
Research Focus
Key Achievements
Top Papers
- 1